FROM ABBEY
A glimpse of what families are helping us see
This is only a glimpse—not the whole ASH1L story. What began with the questions I had for my daughter has grown into a shared effort to understand children and adults across the ASH1L community: how they develop, what changes their access to skills, what helps, what returns, and why their courses can be so different.
FROM DIAGNOSIS TO TIMELINEWhy this family-led timeline matters—and the first contrast that changed my thinking.
WHY I AM SHARING IT
The diagnosis gave us a name. Families began giving it a timeline.
When my daughter, Millie, was diagnosed, I could find lists of possible features, but not the answers I needed. What changes with age? What appears only during illness, pain, constipation, poor sleep, puberty, seizures, or medication exposure? Which skills are still developing, which become temporarily harder to access, and which return after the body stabilizes?
As families began sharing records—and the history between appointments—I could see both overlap and divergence. Early developmental vulnerability may be shared, but later courses separate across sex, variant class, exact genetic matches, additional findings, interventions, and life stage. Those differences are not noise. They are where the strongest research questions begin.
This page is a glimpse, not the whole ASH1L story. It uses de-identified examples from 15 detailed histories to identify questions; it does not prove causation or predict one person’s course.
THE FIVE-MINUTE OVERVIEW
6 findings that organize the deeper record.
These 6 findings summarize 15 detailed histories with an exact ASH1L sequence variant documented: 11 loss-of-function histories—7 female and 4 male—and 4 missense histories. They do not show how common any finding is among all 63 connected people.
A skill may still be present even when it becomes harder to use.
Across the detailed histories, a person’s ability to use a skill can change with sleep, pain, bowel problems, seizures, illness, sensory overload, medication, or recovery.
Open the evidence →02Age coverage currently explains more than sex alone.
The 7 detailed histories of females with loss-of-function variants extend into adulthood; the 4 male histories stop by about age twelve. Later differences cannot yet be attributed to sex.
Open the evidence →03Variant type and location can guide research, but they cannot predict a person’s future.
The 11 loss-of-function and 4 missense histories can be compared by exact variant, type, location, and inheritance, but none of those features can predict an individual course.
Open the evidence →04The timing of a change can be as important as the symptom itself.
Seizures, EEG findings, sleep, ear, nose and throat problems, digestive symptoms, memory, movement, and recovery answer different questions even when they change during the same period.
Open the evidence →05A response must be separated outcome by outcome.
The available histories show why symptom burden, alertness, function, adverse effects, and recovery cannot be compressed into one label such as “better” or “failed.”
Open the evidence →06Whole-body and cancer observations can guide research, but they do not define new syndromes.
Information documented in medical records and reported by families supports careful studies over time and in relevant cells or tissues without showing cause, frequency, cancer risk, or a need for special screening.
Open the evidence →DETAILED EVIDENCE
Explore 6 evidence chapters.
Every de-identified example, evidence label, interpretive limit, counterclaim, and proposed next measurement remains available. Open only the chapter you need.
METHODS & TERMS
The sitewide evidence rules are kept in one place.
Methods & Privacy explains the evidence-label definitions, count rules, missing-information framework, and privacy approach used throughout ASH1L.org.
A genetic result tells us where to look. A life course tells us what the gene may actually mean for a person.
— Abbey